EUVIMEDEUVIMED entdecken
Multizentrische Studie

High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study

Francis Maren Konermann, Nele Gessler, Peter Wohlmuth, Juergen Behr, Johannes Feldhege, Christian Gloeckner, Melanie A Gunawardene, Klaus R Herrlinger, Thomas Hoelting, Ulrich-Frank Pape, Niels Reinmuth, Axel Stang und 3 weitere

Oncology Research and Treatment · 2023

DOI: 10.1159/000529788 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Oncology Research and Treatment, 2023. Verfasst von Francis Maren Konermann und 14 weiteren Autor:innen. Beteiligte Einrichtung: Asklepios Medical School Hamburg, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: COVID-19, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

SARS-CoV-2 infected patients with cancer have a worse outcome including a significant higher mortality, compared to non-cancer patients. However, limited data are available regarding in-hospital mortality during the Omicron phase of the pandemic. Therefore, the aim of the study was the comparison of mortality in patients with history of cancer and patients with active cancer disease during the different phases of the COVID-19 pandemic, focusing on the current Omicron variant of concern.

Methods

We conducted a multicenter, observational, epidemiological cohort study at 45 hospitals in Germany. Until July 20, 2022, all adult hospitalized SARS-CoV-2 positive patients were included. The primary endpoint was in-hospital mortality regarding cancer status (history of cancer and active cancer disease) and SARS-CoV-2 virus type.

Results

From March 11, 2020, to July 20, 2022, a total of 27,490 adult SARS-CoV-2 positive patients were included in the study. 2,578 patients (9.4%) had diagnosis of cancer, of whom 1,065 (41.3%) had history of cancer, whereas 1,513 (58.7%) had active cancer disease. Overall 3,749 out of the total of 27,490 patients (13.6%) died during the hospital stay. Patients with active cancer disease had a significantly higher mortality compared to patients without cancer diagnosis, in both phases of the pandemic (wild-type to Delta: OR 1.940 [1.646–2.285]); Omicron: 2.864 [2.354–3.486]). After adjustment to co-variables, SARS-CoV-2 infected patients with active cancer disease had the highest risk for in-hospital mortality compared to the other groups, in both phases of the pandemic.

Conclusion

The CORONA Germany study indicates that hospitalized patients with active cancer disease are at high risk of death during a SARS-CoV-2 infection. Mortality of patients with history of cancer improved to nearly the level of non-cancer patients during Omicron phase.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19NeoplasmsAdultHumansSARS-CoV-2Hospital MortalityPandemicsCohort StudiesGermany

Stichwörter der Autor:innen

COVID-19CancerMortalityOmicronSARS-CoV-2

Autor:innen und Institutionen

  • Asklepios Medical School Hamburg, Semmelweis University, Budapest, Hungary.
  • Department of Cardiology and Internal Intensive Care Medicine, Asklepios Hospital St. Georg, Hamburg, Germany.
  • Asklepios Proresearch, Research institute, Hamburg, Germany.
  • Asklepios Tumorzentrum Hamburg, Hamburg, Germany.
  • Department of Pneumology, Asklepios Hospital Munich-Gauting, Member of the German Center for Lung Research, Gauting, Germany.
  • Department of Internal Medicine, Asklepios Hospital Oberviechtach, Oberviechtach, Germany.

Zitieren

APA

Konermann, F. M., Gessler, N., Wohlmuth, P., Behr, J., Feldhege, J., Gloeckner, C., Gunawardene, M. A., Herrlinger, K. R., Hoelting, T., Pape, U. F., Reinmuth, N., Stang, A., Sheikhzadeh, S., Arnold, D., & Wesseler, C. (2023). High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study. Oncology Research and Treatment. https://doi.org/10.1159/000529788

Vancouver

Konermann FM, Gessler N, Wohlmuth P, Behr J, Feldhege J, Gloeckner C, et al. High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study. Oncology Research and Treatment. 2023. doi:10.1159/000529788

BibTeX
@article{Konermann2023,
  author = {Konermann, Francis Maren and Gessler, Nele and Wohlmuth, Peter and Behr, Juergen and Feldhege, Johannes and Gloeckner, Christian and Gunawardene, Melanie A and Herrlinger, Klaus R and Hoelting, Thomas and Pape, Ulrich-Frank and Reinmuth, Niels and Stang, Axel and Sheikhzadeh, Sara and Arnold, Dirk and Wesseler, Claas},
  title = {High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study},
  journal = {Oncology Research and Treatment},
  year = {2023},
  doi = {10.1159/000529788}
}
Kostenlos starten →